Cyr61 (CCN1) is a novel target for Zometa (zoledronic acid) in breast cancer bone metastasis.

被引：0
|
作者：
Espinoza, I
Liu, H.
Dimri, M.
Lupu, R.
机构：
[1] ENHRI, Evanston, IL USA
[2] Northwestern Univ, Chicago, IL 60611 USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225S / 226S
页数：2
相关论文
共 50 条
  • [1] CCN1 (CYR61): Two faces in cancer
    不详
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (05) : 473 - 474
  • [2] When Breast Cancer Wants to Spread, Suppress CYR61/CCN1
    Hellinger, Johanna
    Silke, Huechel
    Goetz, Lena
    Bauerschmitz, Gerd
    Emons, Guenter
    Gruendker, Carsten
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 13 - 13
  • [3] Functional domains of CCN1 (Cyr61) regulate breast cancer progression
    O'Kelly, James
    Chung, Alice
    Lemp, Nathan
    Chumakova, Katya
    Yin, Dong
    Wang, He-Jing
    Said, Jonathan
    Gui, Dorina
    Miller, Carl W.
    Karlan, Beth Y.
    Koeffler, H. Phillip
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (01) : 59 - 67
  • [4] CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance
    Zhao, Gexin
    Huang, Bau-Lin
    Rigueur, Diana
    Wang, Weiguang
    Bhoot, Chimay
    Charles, Kemberly R.
    Baek, Jongseung
    Mohan, Subburaman
    Jiang, Jie
    Lyons, Karen M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (06) : 1076 - 1089
  • [5] The Roles of CCN1/CYR61 in Pulmonary Diseases
    Zhu, Yin
    Almuntashiri, Sultan
    Han, Yohan
    Wang, Xiaoyun
    Somanath, Payaningal R.
    Zhang, Duo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 16
  • [6] CYR61/CCN1: A Novel Mediator of Epidermal Hyperplasia and Inflammation in Psoriasis?
    Quan, Taihao
    Johnston, Andrew
    Gudjonsson, Johann E.
    Fisher, Gary J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (11) : 2562 - 2564
  • [7] Functional properties and intracellular signaling of CCN1/Cyr61
    Chen, Ying
    Du, Xiao-Yan
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (06) : 1337 - 1345
  • [8] Zoledronic acid-induced suppression of invasive phenotypes of pancreatic cancer cells is mediated through downregulation of CYR61/CCN1
    Ghosh, Arnab
    Sarkar, Sandipto
    Ghosh, Sonia
    Ray, Priyanka
    Quadir, Mohi
    Banerjee, Sushanta K.
    Banerjee, Snigdha
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [9] CCN1, a Candidate Target for Zoledronic Acid Treatment in Breast Cancer
    Espinoza, Ingrid
    Liu, Hong
    Busby, Robert
    Lupu, Ruth
    [J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10 (05) : 732 - 741
  • [10] CCN1/CYR61: the very model of a modern matricellular protein
    Lester F. Lau
    [J]. Cellular and Molecular Life Sciences, 2011, 68 : 3149 - 3163
12345